The Department of Health and Social Care has announced that every baby born in England will be screened for spinal muscular atrophy (SMA) starting in October 2026, three months earlier than originally planned. The rollout will continue through 2027 until all newborn screening laboratories across the UK offer the test.
What Is Spinal Muscular Atrophy?
SMA is a rare genetic condition that causes muscle weakness and wasting. In severe cases, it can affect breathing and swallowing. Early diagnosis through newborn screening allows for timely treatment, which can significantly improve outcomes for affected children.
How the Screening Works
The screening involves a simple heel prick test to collect a small blood sample from the baby shortly after birth. This is already used to screen for other conditions.
Support from Charities and Campaigners
Giles Lomax, chief executive of Spinal Muscular Atrophy UK, said: “This is a hugely important step forward. When newborn screening for SMA begins later this year in October, thousands of babies will benefit from earlier diagnosis and access to life-changing treatment.”
Andy Fletcher, chief executive of Muscular Dystrophy UK, added: “The decision to introduce newborn screening for SMA across England is a landmark moment for the SMA community and the many partners who have spent years working to make it a reality.”
Little Mix singer Jesy Nelson, whose twin daughters have SMA, campaigned for universal screening. She said: “After years of campaigning, it means so much to see the heel-prick test for SMA begin rolling out from October, with implementation continuing throughout 2027 until every newborn screening laboratory across the UK is offering the test. Today is a day of hope. This is a victory for every family affected by SMA. While it can’t change the future of our children, I know it marks the beginning of a brighter future for future SMA families.”
